Xiaorui Li

1.6k total citations · 1 hit paper
77 papers, 1.2k citations indexed

About

Xiaorui Li is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Xiaorui Li has authored 77 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 13 papers in Oncology and 11 papers in Immunology. Recurrent topics in Xiaorui Li's work include Natural product bioactivities and synthesis (5 papers), Hydrogels: synthesis, properties, applications (5 papers) and Vibrio bacteria research studies (4 papers). Xiaorui Li is often cited by papers focused on Natural product bioactivities and synthesis (5 papers), Hydrogels: synthesis, properties, applications (5 papers) and Vibrio bacteria research studies (4 papers). Xiaorui Li collaborates with scholars based in China, United States and Canada. Xiaorui Li's co-authors include Pengcheng Du, Xiaosheng Yan, Yun‐Bao Jiang, Zhao Li, Yirong Mo, Qiong Zhang, Bing Wang, Lili Huang, Xiaoyuan Duan and Xiaojie Wang and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Xiaorui Li

68 papers receiving 1.2k citations

Hit Papers

Gut microbiota as a new target for anticancer therapy: fr... 2025 2026 2025 5 10 15 20
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Gut microbiota as a new target for anticancer therapy: from mechanism to means of regulation
    2025 20 citations Xiaorui Li, Guangzhen Wu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaorui Li China 21 480 237 178 169 129 77 1.2k
Qianqian Jiang China 19 626 1.3× 258 1.1× 141 0.8× 95 0.6× 73 0.6× 63 1.2k
Bo Hou China 25 783 1.6× 310 1.3× 241 1.4× 149 0.9× 199 1.5× 66 1.9k
Yanhua Wang China 23 575 1.2× 364 1.5× 130 0.7× 40 0.2× 95 0.7× 85 1.3k
Michael Wright United Kingdom 25 1.1k 2.3× 177 0.7× 203 1.1× 167 1.0× 138 1.1× 80 2.0k
Raphael Nudelman Israel 13 601 1.3× 87 0.4× 107 0.6× 68 0.4× 118 0.9× 22 1.2k
Mehdi Rajabi United States 21 960 2.0× 153 0.6× 420 2.4× 205 1.2× 263 2.0× 54 1.9k
Danyang Wang China 24 807 1.7× 61 0.3× 346 1.9× 150 0.9× 95 0.7× 62 1.4k
Jean‐Christophe Garrigues France 17 367 0.8× 51 0.2× 155 0.9× 76 0.4× 182 1.4× 46 1.1k
Aihua Zou China 25 965 2.0× 50 0.2× 253 1.4× 215 1.3× 221 1.7× 56 1.8k

Countries citing papers authored by Xiaorui Li

Since Specialization
Citations

This map shows the geographic impact of Xiaorui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaorui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaorui Li more than expected).

Fields of papers citing papers by Xiaorui Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaorui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaorui Li. The network helps show where Xiaorui Li may publish in the future.

Co-authorship network of co-authors of Xiaorui Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaorui Li. A scholar is included among the top collaborators of Xiaorui Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaorui Li. Xiaorui Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pan, Jie, Wenjin Zhang, Huiying Qin, et al.. (2025). Design, synthesis and cytotoxic activity of novel lipophilic cationic derivatives of diosgenin and sarsasapogenin. Bioorganic & Medicinal Chemistry Letters. 119. 130094–130094. 1 indexed citations
3.
Li, Xiaorui, et al.. (2025). The impact of body mass index on the efficacy of CDK4/6 inhibitors in patients with metastatic breast cancer. Annals of Medicine. 57(1). 2597068–2597068.
4.
Liu, Yuanxin, Jie Qin, Xiaorui Li, & Guangzhen Wu. (2024). Oxysterols in tumor immune microenvironment (TIME). The Journal of Steroid Biochemistry and Molecular Biology. 245. 106634–106634. 1 indexed citations
5.
Li, Xiaorui, Lingyu Kong, Shuxin Yin, et al.. (2024). Palladium‐Catalyzed Atroposelective Suzuki–Miyaura Coupling to Construct Axially Chiral Tetra‐Substituted α‐Boryl Styrenes. Advanced Science. 11(24). e2309706–e2309706. 8 indexed citations
6.
Wen, Shubo, Xiaorui Li, Shuai Zhang, et al.. (2024). Development of a RPA-CRISPR/Cas12a based rapid visual detection assay for Porcine Parvovirus 7. Frontiers in Veterinary Science. 11. 1440769–1440769. 3 indexed citations
7.
Li, Xiaorui, et al.. (2024). Diversity and Complexity of CTXΦ and Pre-CTXΦ Families in Vibrio cholerae from Seventh Pandemic. Microorganisms. 12(10). 1935–1935. 1 indexed citations
8.
Wang, Shisheng, Xiaorui Li, Ning Deng, et al.. (2023). Synthesis and Biological Evaluation of Oleanolic Acid Derivatives with Electrophilic Warheads as Antitumor Agents. Future Medicinal Chemistry. 15(9). 769–790. 3 indexed citations
9.
10.
Yao, Wanxiang, et al.. (2022). Research on the influence of indoor thermal environment and activity levels on thermal comfort in protective clothing. Energy and Buildings. 279. 112681–112681. 20 indexed citations
11.
12.
Liu, Jing, Yinglong Hou, Wei Zhang, et al.. (2019). Dihydroartemisinin Induces Endothelial Cell Autophagy through Suppression of the Akt/mTOR Pathway. Journal of Cancer. 10(24). 6057–6064. 39 indexed citations
13.
Fu, Ling, Xiaorui Li, Chuang Zhang, et al.. (2018). Generation and characterization of a paclitaxel-resistant human gastric carcinoma cell line. Anti-Cancer Drugs. 29(6). 491–502. 13 indexed citations
14.
Fu, Dong‐Jun, Ling Fu, Yingchao Liu, et al.. (2017). Structure-Activity Relationship Studies of β-Lactam-azide Analogues as Orally Active Antitumor Agents Targeting the Tubulin Colchicine Site. Scientific Reports. 7(1). 12788–12788. 37 indexed citations
15.
Huang, Yujie, Kai Zhao, Yang Hu, et al.. (2015). Wogonoside inhibits angiogenesis in breast cancer via suppressing Wnt/β‐catenin pathway. Molecular Carcinogenesis. 55(11). 1598–1612. 42 indexed citations
16.
Feng, Hao, Xiaoyuan Duan, Qiong Zhang, et al.. (2013). The target gene of tae‐ miR164 , a novel NAC transcription factor from the NAM subfamily, negatively regulates resistance of wheat to stripe rust. Molecular Plant Pathology. 15(3). 284–296. 146 indexed citations
17.
Li, Xiaorui, et al.. (2011). Observation of Treating Advanced Breast Cancer with Ginsenoside Rg3 Combining with Capecitabine. Zhongliu fangzhi yanjiu. 38(3). 319–321. 1 indexed citations
18.
Li, Xiaorui. (2010). Influences and mechanism on ginsenoside Rg3 to prolong survival time of the patients who accepted the operation. 1 indexed citations
19.
Li, Xiaorui. (2010). Influences of ginsenoside Rg3 on immune function and fatigue of the postoperative patients with non-small cell lung cancer. 2 indexed citations
20.
Li, Xiaorui. (2008). Optimization of Refined Production of Huangqi Granule With Pottery Membrane. Lishizhen Medicine and Materia Medica Research. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qianqian Jiang Breakdown of academic impact, for papers by Bo Hou Breakdown of academic impact, for papers by Yanhua Wang Breakdown of academic impact, for papers by Michael Wright Breakdown of academic impact, for papers by Raphael Nudelman Breakdown of academic impact, for papers by Mehdi Rajabi Breakdown of academic impact, for papers by Danyang Wang Breakdown of academic impact, for papers by Jean‐Christophe Garrigues Breakdown of academic impact, for papers by Aihua Zou
Rankless by CCL
2026